These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1588289)

  • 1. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.
    Kaplan G; Walsh G; Guido LS; Meyn P; Burkhardt RA; Abalos RM; Barker J; Frindt PA; Fajardo TT; Celona R
    J Exp Med; 1992 Jun; 175(6):1717-28. PubMed ID: 1588289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.
    Smith CH; Allen MH; Groves RW; Barker JN
    Br J Dermatol; 1998 Aug; 139(2):239-46. PubMed ID: 9767237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo.
    Braunstein S; Kaplan G; Gottlieb AB; Schwartz M; Walsh G; Abalos RM; Fajardo TT; Guido LS; Krueger JG
    J Invest Dermatol; 1994 Oct; 103(4):601-4. PubMed ID: 7930689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients.
    Kaplan G; Nusrat A; Sarno EN; Job CK; McElrath J; Porto JA; Nathan CF; Cohn ZA
    Am J Pathol; 1987 Aug; 128(2):345-53. PubMed ID: 3113256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
    Kaplan G; Kiessling R; Teklemariam S; Hancock G; Sheftel G; Job CK; Converse P; Ottenhoff TH; Becx-Bleumink M; Dietz M
    J Exp Med; 1989 Mar; 169(3):893-907. PubMed ID: 2494293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
    Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
    Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans' cell/macrophage accumulation, and dermal fibrosis.
    Xing Z; Gauldie J; Tremblay GM; Hewlett BR; Addison C
    Lab Invest; 1997 Dec; 77(6):615-22. PubMed ID: 9426399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor.
    Hovgaard D; Mortensen BT; Schifter S; Nissen NI
    Eur J Haematol; 1993 Jan; 50(1):32-6. PubMed ID: 8436212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization.
    Mann A; Breuhahn K; Schirmacher P; Blessing M
    J Invest Dermatol; 2001 Dec; 117(6):1382-90. PubMed ID: 11886498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA
    N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal granulocyte-macrophage colony-stimulating factor alters cutaneous antigen-presenting cells and differentially affects local versus distant immunization in humans.
    Kremer IB; Stevens SR; Gould JW; DiCarlo J; Quinby GE; Cooper KD
    Clin Immunol; 2000 Jul; 96(1):29-37. PubMed ID: 10873425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
    Kaplan G; Britton WJ; Hancock GE; Theuvenet WJ; Smith KA; Job CK; Roche PW; Molloy A; Burkhardt R; Barker J
    J Exp Med; 1991 Apr; 173(4):993-1006. PubMed ID: 2007862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
    Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
    Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing.
    Ure I; Partsch B; Wolff K; Petzelbauer P
    Br J Dermatol; 1998 Feb; 138(2):277-82. PubMed ID: 9602874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.
    Brem H; Howell R; Criscitelli T; Senderowicz A; Siegart N; Gorenstein S; Gillette B
    Surg Technol Int; 2018 Jun; 32():61-66. PubMed ID: 29611156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.
    Vargel I; Erdem A; Ertoy D; Pinar A; Erk Y; Altundag MK; Gullu I
    Ann Plast Surg; 2002 Dec; 49(6):646-53. PubMed ID: 12461449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice.
    Fang Y; Gong SJ; Xu YH; Hambly BD; Bao S
    Br J Dermatol; 2007 Sep; 157(3):458-65. PubMed ID: 17553038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.